Evaluation of Postoperative Pain and Satisfaction After Orbital Fracture Repair

Hui Bae Harold Lee
{"title":"Evaluation of Postoperative Pain and Satisfaction After Orbital Fracture Repair","authors":"Hui Bae Harold Lee","doi":"10.46889/joar.2024.5107","DOIUrl":null,"url":null,"abstract":"Objective: To correlate clinical outcomes in postoperative pain managed with opioid medications after orbital fracture repairs.\n\nMethods: A prospective observational study of all patients who underwent orbital fracture repairs and postoperative pain managed with hydrocodone-acetaminophen, oxycodone-acetaminophen or tramadol for three days was performed. Collected data included numerical pain rating scores, type of fractures, patient satisfaction, side effects and non-medicinal interventions. International Pain Outcomes (IPO) questionnaire was completed at postoperative week one visit.\n\nResults: Twenty-nine patients who underwent orbital fracture repairs and completed the IPO questionnaire reported having taken an average of 74.8 +/- 36.6 Morphine Milligram Equivalent (MME) in the first week after the surgery from 102.5 +/- 10.0 MME of total opioids prescribed (Table 1). The amount of opioids used was not related to patient satisfaction or pain relief (p>0.05). Smoking status showed a moderate correlation and linear association with total MME taken by patients (spearman correlation coefficient 0.34, p=0.051). Although patients reported 69.4 +/- 24.9% overall pain relief and 9 out of 10 (median, IQR 5-10) scores in satisfaction with the pain regimen, 27.8% of patients reported needing more pain medication. This group reported higher levels of anxiety and lower satisfaction scores (p<0.001). They reported having taken more opioids than those who did not report the need for additional pain medications (p=0.07).\n\nConclusion: Postoperative pain is managed with less than the prescribed amount of opioids after orbital fracture repairs in most patients. Anxious patients who had more opioids than average in the postoperative period expressed low satisfaction.","PeriodicalId":348405,"journal":{"name":"Journal of Ophthalmology and Advance Research","volume":"11 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmology and Advance Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46889/joar.2024.5107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To correlate clinical outcomes in postoperative pain managed with opioid medications after orbital fracture repairs. Methods: A prospective observational study of all patients who underwent orbital fracture repairs and postoperative pain managed with hydrocodone-acetaminophen, oxycodone-acetaminophen or tramadol for three days was performed. Collected data included numerical pain rating scores, type of fractures, patient satisfaction, side effects and non-medicinal interventions. International Pain Outcomes (IPO) questionnaire was completed at postoperative week one visit. Results: Twenty-nine patients who underwent orbital fracture repairs and completed the IPO questionnaire reported having taken an average of 74.8 +/- 36.6 Morphine Milligram Equivalent (MME) in the first week after the surgery from 102.5 +/- 10.0 MME of total opioids prescribed (Table 1). The amount of opioids used was not related to patient satisfaction or pain relief (p>0.05). Smoking status showed a moderate correlation and linear association with total MME taken by patients (spearman correlation coefficient 0.34, p=0.051). Although patients reported 69.4 +/- 24.9% overall pain relief and 9 out of 10 (median, IQR 5-10) scores in satisfaction with the pain regimen, 27.8% of patients reported needing more pain medication. This group reported higher levels of anxiety and lower satisfaction scores (p<0.001). They reported having taken more opioids than those who did not report the need for additional pain medications (p=0.07). Conclusion: Postoperative pain is managed with less than the prescribed amount of opioids after orbital fracture repairs in most patients. Anxious patients who had more opioids than average in the postoperative period expressed low satisfaction.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
眼眶骨折修复术后疼痛和满意度评估
目的观察眼眶骨折修补术后使用阿片类药物治疗术后疼痛的临床效果:对所有接受眼眶骨折修补术的患者进行前瞻性观察研究,并对术后疼痛进行为期三天的氢可酮-乙酰氨基酚、羟考酮-乙酰氨基酚或曲马多治疗。收集的数据包括疼痛评分、骨折类型、患者满意度、副作用和非药物干预。术后一周访视时填写国际疼痛结果(IPO)问卷:29 名接受眼眶骨折修补术并填写了 IPO 问卷的患者表示,术后第一周平均服用了 74.8 +/- 36.6 吗啡毫克当量(MME),而阿片类药物处方总量为 102.5 +/- 10.0 MME(表 1)。阿片类药物的用量与患者满意度或疼痛缓解程度无关(P>0.05)。吸烟状况与患者的阿片类药物总用量呈中度相关和线性关系(矛曼相关系数 0.34,P=0.051)。尽管患者报告的总体疼痛缓解率为 69.4 +/- 24.9%,对疼痛治疗方案的满意度为 10 分中的 9 分(中位数,IQR 5-10),但 27.8% 的患者报告需要更多的止痛药物。这组患者焦虑程度较高,满意度得分较低(P<0.001)。与未报告需要额外止痛药物的患者相比,他们报告服用了更多的阿片类药物(P=0.07):结论:大多数患者在眼眶骨折修复术后使用的阿片类药物都少于规定剂量。术后使用阿片类药物较多的焦虑患者满意度较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Surgical Treatment of a Large-Angle Post Traumatic Hypertropia by The Inverse Knapp Procedure: A Case Report Correlation Between Primary Open Angle Glaucoma and Serum Lipids Diagnosis and Management of Orbital Cellulitis in a Reference Center in Senegal Evaluation of Postoperative Pain and Satisfaction After Orbital Fracture Repair Epidemio-Clinical Profile of Onchocerciasis in Sambwa in the Democratic Republic of Congo
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1